Showing results (2161-2170 of 3,888) with videos related to
Sort By:
Pageof 389
Cancer Biology & Therapy|January 29, 2026
Glutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progressionChunyan Wang, Hongyan Zhang, Chaonan Guan, et al.Cancer Biology & Therapy|March 27, 2025
Bibliometric analysis of autophagy in the diagnosis and treatment of osteosarcoma: a bibliometric analysis (2007-2023)Min Zhu, Wei Xiang, Zhoujun Zhu, et al.Cancer Biology & Therapy|January 30, 2013
Mechanisms of resistance to EGFR targeted therapiesGorjan Hrustanovic, Bianca J Lee, Trever G BivonaCancer Biology & Therapy|January 30, 2013
Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cellsNishant Gandhi, Aaron T Wild, Sivarajan T Chettiar, et al.Cancer Biology & Therapy|January 30, 2013
Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: a Sarah Cannon Research Institute phase II trialJeffrey R Infante, Hendrik-Tobias Arkenau, Johanna C Bendell, et al.Cancer Biology & Therapy|January 30, 2013
PKC signaling in glioblastomaAnália do Carmo, Joana Balça-Silva, Diana Matias, et al.Cancer Biology & Therapy|January 31, 2013
The RON receptor tyrosine kinase is a potential therapeutic target in Burkitt lymphomaXiangmin Tong, Xuewu Zhang, Jian Fan, et al.Cancer Biology & Therapy|January 10, 2013
A novel p21 attenuator which is structurally related to sorafenibHiromi I Wettersten, Sung Hee Hwang, Cuiwen Li, et al.Cancer Biology & Therapy|February 6, 2013
Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteasesPratima Nangia-Makker, Tirza Raz, Larry Tait, et al.Cancer Biology & Therapy|November 30, 2012
Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheresMalgorzata Czyz, Kamila Koprowska, Malgorzata Sztiller-SikorskaPageof 389